Intranasal Drug Delivery

Global Market Trajectory & Analytics

MCP-1795

EXECUTIVE ENGAGEMENTS

OUTREACH

13024
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1563
Interactions with Platform & by Email

PARTICIPANTS

391
Unique # Participated

VALIDATIONS

176
Responses Validated*

COMPETITORS

64
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

213

PAGES

307

EDITION

15

PRICE

USD $5600


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Spray, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$19.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drop segment is readjusted to a revised 5% CAGR for the next 7-year period.
The Intranasal Drug Delivery market in the U.S. is estimated at US$12.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.8 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.
In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$8 Billion in the year 2020 will reach a projected size of US$10 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.8 Billion by the year 2027, while Latin America will expand at a 4.5% CAGR through the analysis period.

SELECT PLAYERS

Aegis Therapeutics LLC; AptarGroup, Inc.; AstraZeneca Plc; Becton Dickinson and Company; GlaxoSmithKline Plc; Johnson & Johnson; Marina Biotech, Inc.; MedImmune, Inc.; Merck & Co., Inc.; Nemera; Novartis AG; OptiNose US Inc.; Pfizer Inc.; Valeant Pharmaceuticals International, Inc.

SEGMENTS

» Dosage Form (Spray, Drop, Gel, Powder) » Application (Nasal Congestion, Rhinitis, Asthma, Other Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
A Prelude
Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier
Recent Market Activity
Factors Inhibiting Nose-to-Brain Transportation of Drugs
Bioavailability: An Important Facet of Intranasal Drug Delivery
Outlook
Nasal Drug Delivery Devices & Equipment
Traditional Vs. Advanced Intranasal Drug Formulation Types
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies
Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
Pharmaceutical and Medical Device Companies Vying to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients
The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
Intranasal Corticosteroids - A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease
Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight
Innovation in Drug Delivery: A Talisman for Success
Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications
Controlled Release Technology Is the Buzz Word
Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery
Tight Junction Biology: A Key Speed Breaker in Commercialization
RNA Interference (RNAi): A Tool to Manipulate Tight Junctions
Research Studies Authenticate Benefits of Bi-Directional Nasal Drug Delivery
Growing Interest for Preservative-free Nasal Spray Formulations
Multi-Dose Containers Developed to Offer Resistance against Microbial Contamination
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Spray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Spray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Spray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Drop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Drop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Drop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Gel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Powder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Nasal Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Nasal Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nasal Congestion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
China Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
France Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
India Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled: 64

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com